Global

eShop

Tel

Tel+65 89686988
E-mail

E-mailmarketing@cytoniche.com
TOP

Knowledge Centre

Home page

全部

全部
产品管理
新闻资讯
介绍内容
企业网点
常见问题
企业视频
企业图册

Product Videos

17 Jul,2026

An End-to-End, Scalable and Intelligent MSC Manufacturing Platform

20 May,2025

CytoNiche Microcarrier Series Portfolio

10 Jun,2025

3D FloTrix™ microSPIN Multiplex System

Catalogues & Brochures

12 Jun,2025

Total Solution for Mass Manufacturing of Cells

10 Jul,2026

Producing Billions of Stem Cells Effortlessly: Efficiency Meets Affordability

10 Jul,2026

Scaling Up Stem Cell-derived Exosomes to Trillions with Ease: High Yield, Smart Costs

27 Apr,2025

Unlock the Future of Cell Therapy with CytoNiche Microcarriers

Scientific Insights

05 Oct,2026

The CMC-Driven Era: A Deep Interpretation of China’s New Regulatory Framework for Exosomes and Cell Derivatives

25 Sep,2026

Quality Control of Stem Cell-Derived Extracellular Vesicles (Part II): From Potency to Safety

14 Sep,2026

Quality Control of Stem Cell-Derived Extracellular Vesicles (Part Ⅰ): From Cell Banking to Multidimensional Product Characterisation

24 Aug,2026

Engineering Commercial-Scale MSC-Derived Extracellular Vesicle Manufacturing

30 Jul,2026

Tracing Quality Upstream: How MSC Quality Determines the Critical Quality Attributes and Therapeutic Potential of Exosomes

12 Jul,2026

Microcarrier Selection as a Strategic Imperative in Commercial-Scale Cell Therapy

Technical Resources

Jun 12,2025

coming soon

Technical Resources

05 Oct,2026

The CMC-Driven Era: A Deep Interpretation of China’s New Regulatory Framework for Exosomes and Cell Derivatives

25 Sep,2026

Quality Control of Stem Cell-Derived Extracellular Vesicles (Part II): From Potency to Safety

14 Sep,2026

Quality Control of Stem Cell-Derived Extracellular Vesicles (Part Ⅰ): From Cell Banking to Multidimensional Product Characterisation

24 Aug,2026

Engineering Commercial-Scale MSC-Derived Extracellular Vesicle Manufacturing

30 Jul,2026

Tracing Quality Upstream: How MSC Quality Determines the Critical Quality Attributes and Therapeutic Potential of Exosomes

12 Jul,2026

Microcarrier Selection as a Strategic Imperative in Commercial-Scale Cell Therapy

Knowledge Studio

11 Sep,2026

The Manufacturing Challenge Behind the Future of Exosome Therapies

11 Sep,2026

How Can We Make EV Manufacturing More Scalable?

01 Sep,2026

From 2D to Bioreactors: Rethinking How Exosomes Are Manufactured

14 Aug,2026

How to Choose the Right Exosome Manufacturing Platform

07 Aug,2026

Why Cell Culture Conditions Matter for Exosome Quality

05 Aug,2026

Exosome Quality Starts with the Cell: Tissue Source, Passage Number & Donor Variability

Publications

Jun 12,2025

Leading a new era of cell industrialization

E-mail

marketing@cytoniche.com

Address

3D FloTrix™ Experience Hub

TEE International Limited, Level 6, 25 Bukit Batok Street 22, Singapore 659591

https://www.linkedin.com/company/cytoniche/?viewAsMember=true

CytoNiche, FloTrix, TableTrix, RecomTrix, Architect for Cells and the microcarrier icon are trademarks of CytoNiche Biotech.

Tibet ICP Registration No. 11010802037749

We are always looking forward to hear from you.

Products of Interest

First name

Last Name

E-Mail Address

Phone Number

Company

Country

Your Message to Us

I accept View Terms of Use

安全验证

Security verification

Submit Your Request